CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization

CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization

The current COVID-19 pandemic has claimed hundreds of thousands of lives and its causative agent, SARS-CoV-2, has infected millions, globally. The highly contagious nature of this respiratory virus has spurred massive global efforts to develop vaccines at record speeds. In addition to enhanced immun...

Full description

Bibliographic Details
Main Authors: Brien K. Haun, Chih-Yun Lai, Caitlin A. Williams, Teri Ann S. Wong, Michael M. Lieberman, Laurent Pessaint, Hanne Andersen, Axel T. Lehrer
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
adjuvant
recombinant subunit
COVID-19
immunogenicity
rapid response
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.599587/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.599587/full

Similar Items